Keytruda 100mg/4ml

Product Description

Keytruda 100mg/4ml are described as an immune-based cancer therapy containing pembrolizumab. Pembrolizumab is an immune checkpoint inhibitor used to treat various advanced or metastatic cancers by strengthening the body's immune response against cancer cells.

Product Overview

Product Name: Keytruda 100mg/4ml
Product Form: Tablets
Pack Size: 1's
Manufactured By: MSD
Used For: Treatment of several advanced cancers
Prescription Required: Yes

How It Works

Pembrolizumab targets the PD-1 receptor on immune cells, blocking its interaction with PD-L1. This reactivates the immune system, enabling it to identify and destroy cancer cells more effectively. It is commonly used in immunotherapy-based cancer treatment plans.

Key Benefits

Helps treat advanced melanoma.
Effective for certain cases of non-small cell lung cancer (NSCLC).
Used for head and neck squamous cell carcinoma (HNSCC).
Supports treatment of urothelial carcinoma.
Helps manage classical Hodgkin lymphoma.
Used in select cases of colorectal and esophageal cancers.
May be recommended for other metastatic cancers depending on specialist evaluation.

How to Use

This medication, as listed, should be taken exactly as directed by an oncologist.
Usage and dosing depend on the cancer type, treatment plan, and patient response.
Follow all medical instructions and do not adjust the dose without consultation.

Side Effects and Precautions

Common Side Effects

Fatigue, nausea, or loss of appetite
Skin reactions such as itching or rash
Diarrhea or constipation
Shortness of breath or cough
Muscle or joint pain
Abnormal liver enzymes indicating possible liver irritation
Immune-related inflammation affecting major organs

Precautions

Requires medical supervision due to risk of immune-related reactions.
Report any new or severe symptoms immediately, especially chest pain, breathing difficulty, or intense abdominal pain.
Use cautiously in patients with autoimmune disorders.
Regular blood tests are recommended to monitor thyroid, liver, and kidney function.
Not recommended during pregnancy or breastfeeding due to potential harm to the baby.

Who Should Use

Patients diagnosed with cancers known to respond to pembrolizumab and who are receiving treatment under oncology supervision.

Storage Instructions

Store according to pharmacy or manufacturer guidelines.
Keep out of the reach of children and away from direct sunlight or heat.

Disclaimer

This medication must be used under strict medical supervision. The information provided does not replace professional medical advice. Always consult your oncologist for diagnosis, treatment planning, and correct usage instructions.